drug

ziftomenib

1 story · latest Aug 12, 2026

Status: FDA approved Nov 2025 · NDA220305
Brand: Komzifti
Code: KO-539
Trials: 3 registered trials in coverage

Relationships

Developed by Kura Oncology, Inc.

Timeline

Kura Oncology posts $9.1 million in KOMZIFTI revenue in second quarter of 2026

Aug 12Quarterly updateKura Oncology, Inc.ziftomenib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.